189 unknown. 189 Phase 3, 42 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 189 | Unknown 189 |
| Phase 2 | 42 | Unknown 42 |
Follow Colonic Diseases: new trials by email Literature Review of Colonic Diseases trials Research Report on Colonic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis celecoxib monotherapy, celecoxib and metformin combination - Familial Adenomatous Polyposis | Phase 3 | Unknown | Yonsei University | 28 | 2024-08-13 | 2024-08-09 |
| Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC CT-P13 - Inflammatory Bowel Diseases | Phase 3 | Unknown | CMC Ambroise Paré | 130 | 2024-07-10 | 2024-07-31 |
| Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial Alpha-ketoglutarate, Placebo, Standard care - Colorectal Cancer | Phase 3 | Unknown | National University Hospital, Singapore | 80 | 2024-05-09 | 2024-10-17 |
| Unravelling Intestinal Fibrosis in Ulcerative Colitis Fibroblast Activation Protein Inhibitor - Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD) | Phase 2 / Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2024-04-03 | 2024-09-19 |
| Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. Mesalazine - Colitis, Ulcerative | Phase 3 | Unknown | Faes Farma, S.A. | 376 | 2024-03-01 | 2023-12-19 |
| Proactive Management of Endoperitoneal Spread in Colonic Cancer Standard surgical treatment, Proactive management, Standard adjuvant systemic chemotherapy - Colon Cancer, Intraperitoneal Rectal Cancer | Phase 3 | Unknown | University of Roma La Sapienza | 140 | 2024-03-01 | 2023-05-06 |
| Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors Dexmedetomidine administered intranasally - Colorectal Cancer | Phase 3 | Unknown | First Affiliated Hospital of Chongqing Medical University | 126 | 2023-12-01 | 2024-04-09 |
| Sulfasalazine in Patients With Metastatic Colorectal Cancer Sulfasalazine - Metastatic Colorectal Cancer | Phase 3 | Unknown | Tanta University | 50 | 2023-09-01 | 2023-11-18 |
| Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® Intravenous (IV) infusions - Ulcerative Colitis | Phase 3 | Unknown | Polpharma Biologics S.A. | 750 | 2023-07-24 | 2025-06-17 |
| Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM mFOLFOX6 + Cetuximab, mFOLFOX 6 - Colorectal Cancer, Liver Metastases | Phase 3 | Unknown | Fudan University | 250 | 2023-07-15 | 2023-07-17 |
| A Study to Evaluate Safety and Efficacy of PBK_M2101 PBK_M2101 2-Day, PBK_M2101 1-Day, Oral Sulfate Tablet 2-Day - Intestinal Disease, Colonic Diseases | Phase 3 | Unknown | Pharmbio Korea Co., Ltd. | 246 | 2023-06-01 | 2023-06-28 |
| Nitazoxanide in Patients With Metastatic Colorectal Cancer Nitazoxanide - Metastatic Colorectal Cancer | Phase 3 | Unknown | Tanta University | 60 | 2023-03-01 | 2023-09-22 |
| Effect of Silymarin in Metastatic Colorectal Cancer Patients Silymarin - Metastatic Colorectal Cancer | Phase 3 | Unknown | Tanta University | 64 | 2022-12-31 | 2023-12-22 |
| the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis Placebo, Diosmin - Ulcerative Colitis | Phase 3 | Unknown | Tanta University | 60 | 2022-12-15 | 2023-04-12 |
| Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status Experimental drug - Colorectal Cancer, Liver Metastases | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2022-10-01 | 2022-06-08 |
| Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage FLUO+ : Intraoperative fluorescence angiography (IOFA) with indocyanine green (ICG). - Colorectal Cancer | Phase 3 | Unknown | Centre Hospitalier Universitaire de Besancon | 1010 | 2022-09-26 | 2024-09-19 |
| A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC TRS003, China-approved Bevacizumab, mFOLFOX6 - Metastatic Colorectal Cancer (CRC) | Phase 3 | Unknown | Zhejiang Teruisi Pharmaceutical Inc. | 126 | 2022-08-01 | 2022-05-18 |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2022-06-01 | 2022-04-22 |
| Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer Celecoxib 200mg, Capecitabine-based chemotherapy - Hand and Foot Syndrome, Erythrodysesthesia Syndrome | Phase 3 | Unknown | Tanta University | 44 | 2022-04-01 | 2022-04-14 |
| Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer Jianpi Huatan dispensing granule, Placebo granule - Colorectal Neoplasms | Phase 3 | Unknown | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 200 | 2021-11-15 | 2022-01-11 |
Showing 20 of 189. Sign in to see all of them.
Colorectal Neoplasms (117) · Colonic Neoplasms (54) · Rectal Neoplasms (29) · Colitis, Ulcerative (23) · Neoplasm Metastasis (16) · Irritable Bowel Syndrome (10) · Crohn Disease (8) · Inflammatory Bowel Diseases (7) · Diarrhea (4) · Adenomatous Polyposis Coli (3) · Abdominal Pain (2) · Anastomotic Leak (2) · Anemia (2) · Anemia, Iron-Deficiency (2) · Breast Neoplasms (2)
Digestive System Diseases (188) · Gastrointestinal Diseases (188) · Intestinal Diseases (188) · Gastrointestinal Neoplasms (151) · Intestinal Neoplasms (151) · Neoplasms by Site (151) · Digestive System Neoplasms (150) · Neoplasms (149) · Rectal Diseases (120) · Colorectal Neoplasms (34) · Pathological Conditions, Signs and Symptoms (33) · Gastroenteritis (28) · Colitis (25) · Pathologic Processes (24)
Fluorouracil (31) · Leucovorin (30) · Oxaliplatin (26) · Capecitabine (20) · Cetuximab (11) · Irinotecan (11) · Bevacizumab (10) · Folfox protocol (10) · Drug Therapy (9) · Chemotherapy, Adjuvant (7) · Laparoscopy (7) · XELOX (7) · Fecal Microbiota Transplantation (5) · Neoadjuvant Therapy (5) · Floxuridine (4)
Fudan University (12) · Sun Yat-sen University (7) · Tanta University (6) · Sixth Affiliated Hospital, Sun Yat-sen University (5) · GERCOR - Multidisciplinary Oncology Cooperative Group (4) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (3) · Chinese University of Hong Kong (3) · Ruijin Hospital (3) · The First Affiliated Hospital with Nanjing Medical University (3) · Xiyuan Hospital of China Academy of Chinese Medical Sciences (3) · Asian Institute of Gastroenterology, India (2) · Assistance Publique - Hôpitaux de Paris (2) · Bonderup, Ole K., M.D. (2) · European Institute of Oncology (2) · Federation Francophone de Cancerologie Digestive (2)
China (61) · France (14) · Italy (12) · Netherlands (10) · United Kingdom (10) · United States (10) · Egypt (8) · Germany (7) · South Korea (7) · Canada (5) · India (5) · Spain (5) · Taiwan (5) · Belgium (4) · Japan (4)
Aimery de Gramont, MD (3) · Aiwen Wu, M.D. (2) · Fumin Zhang, Professor (2) · John N. Primrose, MD (2) · Junkang Liu, Doctor (2) · Ronald Myers, PhD (2) · Rupa Banerjee, MD, DM (2) · Timothy Maughan, MD (2) · Xiaojian Wu, Ph.D. (2) · Xinxiang Li, MD,PhD (2) · Yifeng Wang, MD (2) · Adel Denewer, MD (1) · Agnes Rethy, MD (1) · Ahmet Uygun, Prof (1) · Aiping Zhou, Doctor (1)
PMID 20718753, PMID 22895629, PMID 23599758, PMID 25077927, PMID 26363929, PMID 36306483, PMID 40013523, PMID 41252656, PMID 10400410, PMID 11239312, PMID 11413430, PMID 11491192, PMID 11914441, PMID 12047964, PMID 15273542, PMID 1598671, PMID 16810012, PMID 17005947, PMID 17013448, PMID 17538089, PMID 17943760, PMID 18358928, PMID 18972769, PMID 19011538, PMID 19071061, PMID 19165196, PMID 19554377, PMID 19638912, PMID 19770617, PMID 19786657, PMID 20554319, PMID 20594245, PMID 21569373, PMID 21641636, PMID 21641867, PMID 21899713, PMID 22012809, PMID 22168568, PMID 22314329, PMID 22347818, PMID 23554827, PMID 24050955, PMID 24120480, PMID 24253138, PMID 24566744, PMID 24670844, PMID 24799484, PMID 24815298, PMID 25088940, PMID 25451666
2009 (1), 2018 (1), 2019 (1), 2023 (1), U10CA031946 (1)